Article Versions Notes

Ly AT, Diop D, Diop M, Schacht A-M, Mbengue A, Diagne R, Guisse M, Dompnier J-P, Messias C, Coler RN, et al. The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa. Vaccines. 2025; 13(3):316. https://doi.org/10.3390/vaccines13030316

Ly, Amadou Tidjani, Doudou Diop, Modou Diop, Anne-Marie Schacht, Abdoulaye Mbengue, Rokhaya Diagne, Marieme Guisse, Jean-Pierre Dompnier, Carolina Messias, Rhea N. Coler, and et al. 2025. "The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa" Vaccines 13, no. 3: 316. https://doi.org/10.3390/vaccines13030316

Ly, A. T., Diop, D., Diop, M., Schacht, A.-M., Mbengue, A., Diagne, R., Guisse, M., Dompnier, J.-P., Messias, C., Coler, R. N., Ramos, C. R., Tendeng, J.-N., Ndiaye, S., Marroquin-Quelopana, M., de Carvalho Parra, J., dos Santos, T., Sirianni dos Santos Almeida, M., Mendes-da-Cruz, D. A., Reed, S., ... Tendler, M. (2025). The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa. Vaccines, 13(3), 316. https://doi.org/10.3390/vaccines13030316